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Questions under study: With the reduction in
breast cancer mortality in recent years the aes-
thetic outcome after treatment has gained in-
creasing attention. The aim of this study was to
assess the outcome quality of our single institu-
tion concept of free TRAM flap breast recon-
struction with the aim of providing data to assist
the patient’s decision-making when breast recon-
struction is an option.
Principles/methods: Thirty-two consecutive pa-
tients receiving immediate (n = 14) or delayed (n =
18) breast reconstruction with free transverse rec-
tus abdominis musculocutaneous (TRAM) flaps
were included. The selection of patients was
based on their own wish and the availability of ab-
dominal tissue, without excluding patients at risk
for wound healing complications. Patient data
were assessed prospectively and the aesthetic out-
come was rated after the final result had been
achieved.
Results: Ten patients sustained wound healing
complications (4 of 9 smokers, 8 of 16 patients
with a BMI over 25 kg/m2), 8 of them requiring
revisional surgery. An average of 1.06 corrective
procedures were performed per patient. The
 aesthetic outcome was judged to be good by 20
patients, fair by 5 and poor by 1 patient who sus-
tained severe tissue loss.
Conclusions: Our results revealed that a large
measure of satisfaction is achievable from breast
reconstruction with free TRAM flaps, in spite of
the invasive nature of the procedure and the
 inclusion of patients at risk for wound healing
complications. These data may be used in the
 decision-making process by patients eligible for
breast reconstruction after mastectomy. 
Key words: breast cancer; skin sparing mastec-
tomy; autologous tissue; microsurgery; aesthetic out-
come
Summary
At present breast cancer accounts for the
highest prevalence of malignant diseases in the fe-
male population of industrialised countries. In re-
cent decades breast cancer mortality has been re-
duced thanks to advanced medical technologies,
in particular sophisticated imaging techniques
and refined therapeutic strategies. In line with
this trend, increasing attention has been paid to
the aesthetic outcome after treatment. Currently
the primary goal is preservation of the affected
breast, which can be offered to approximately
70% of patients [1, 2], whereas female integrity
can be reestablished with breast reconstructive
procedures if mastectomy is inevitable for med-
ical reasons or if preferred by the patient. If
metastatic disease has been ruled out immediate
breast reconstruction at the time of the mastec-
tomy is recommended, to avoid the psychological
trauma inflicted by the ablation [3, 4]. As much as
possible of the skin envelope should be preserved,
this being a prerequisite in obtaining the most
natural shape and skin texture of the recon-
structed breast [5]. Provided that proper surgical
indications are respected, oncologic safety has
been confirmed for both immediate breast recon-
struction and skin sparing mastectomy [5–7].
Basically, the breast mound can be recon-
structed with alloplastic (silicone) implants, the
use of autologous flap tissue, or a combination of
both. Most patients are reluctant to harbour for-
eign material in their bodies and thus opt for use
of autologous tissue alone. Various parts of the
body may serve as donor sites, such as the back 
[8, 9], the gluteal area [10, 11] and the abdominal
wall [12]. Due to the general abundance of ab-
dominal panniculus in the breast cancer popula-
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tion, the quality and reliability of the anatomical
blood supply and the aesthetic benefit at the
donor site, the transverse rectus abdominis mus-
culocutaneous (TRAM) flap has become the flap
of choice for this purpose. The flap may be pedi-
cled on the superior epigastric system, as first de-
scribed by Hartrampf et al. in 1982 [12], or it may
be raised as a free flap, pedicled on the inferior
epigastric artery and vein, which are anastomosed
to vessels at the recipient site to reestablish blood
perfusion [13]. Because the flap tissue belongs to
the vascular territory of the inferior epigastric
system, the blood supply to the superiorly pedi-
cled flap depends on the intramuscular arcading
collaterals, whereas the free flap is perfused via its
anatomical vascular axis. In addition, the resulting
abdominal wall defect at the donor site is re-
stricted to the infraumbilical area after free flap
harvesting, whereas the entire rectus muscle
serves as the flap pedicle if the flap is based supe-
riorly. 
For the above reasons, the free TRAM flap is
the preferred method of breast reconstruction at
our institution. Our concept consists in a two ses-
sion approach, volume replacement being the
goal of the first intervention and breast contour-
ing that of the second, possibly combined with re-
construction of the nipple-areola complex (NAC).
The drawback of this concept is its invasive na-
ture, which may deter some patients from choos-
ing it. Being faced with the diagnosis of breast
cancer, selecting the therapeutic option that best
fits the patient is overwhelming, particularly for
immediate reconstruction. Besides the experi-
enced plastic surgeon who should be involved in
the primary planning of the therapeutic strategy,
patients very often seek assistance in their deci-
sion-making process from their physicians and
family doctors [1, 14]. It has been shown that
long-term patient satisfaction depends largely on
preoperative information on the upcoming proce-
dure: a patient is much more ready to accept the
burdens of surgery, with the attendant postopera-
tive pain and discomfort, if she is aware of them
beforehand [15]. On the other hand, many
women regret the decision in the long run if re-
construction was refused [3].
The aim of this study was to assess the out-
come quality of our single institution concept of
free TRAM flap breast reconstruction, with the
aim of providing data useful to the patient in her
decision-making when breast reconstruction is an
option. 
Patients and methods
The study comprises a consecutive series of patients
receiving a free TRAM flap for breast reconstruction at
our institution between January 1998 and February 2003.
The indication for mastectomy was set by the gynaecolo-
gist who transferred the patient to our department and
was commonly based on the suggestions of a senology tu-
mour board. The indication for breast reconstruction,
both immediate and delayed, was determined by the pa-
tient’s wish. Infiltration of the tumour into the skin or
thoracic wall (pT4), palpable regional lymph nodes or
systemic metastases were taken as exclusion criteria for
immediate reconstruction, and the absence of any signs of
recurrence documented in the routine staging procedure
was required for delayed reconstruction. Prerequisites for
selecting a TRAM flap included the availability of suffi-
cient abdominal skin and fat tissue, the absence of median
laparotomy scars and the patient’s preference. There were
no exclusion criteria with regard to risk factors. 
All operations were performed in a two-team ap-
proach consisting of one surgical team working at the
 recipient site (mastectomy or resection of mastectomy
scar, dissection of recipient vessels), and the other team
dissecting the flap. In all immediate reconstructions, lymph-
adenectomy of level I and II was performed routinely.
The skin envelope was left intact as far as possible, de-
pending on where the tumour was located. 
The flap design was marked on the upright patient
on the preoperative day. The adipocutaneous part of the
flap consisted of a horizontal spindle extended between
the superior anterior iliac spines. The vertical amount of
harvested skin and fat was determined by the amount of
remaining skin allowing for direct closure after mobilisa-
tion of the cranial wound margin. The umbilicus was dis-
sected free from the surrounding flap tissue and was rein-
serted into the mobilised cranial abdominal skin at its
original position. The flap was dissected free from the an-
terior rectus sheath by preserving the musculocutaneous
perforator vessels nourishing the adipocutaneous flap
components. The anterior rectus sheath was then spar-
ingly incised around the perforator vessels. A cuff of rec-
tus muscle surrounding the perforators was included in
the flap, and the feeding deep epigastric artery and vein
were dissected free until branching of the external iliac
vessels, where they were transected. Approximately one
third of the muscle circumference was always preserved.
After harvesting of the flap, the anterior rectus sheath was
duplicated and closed using two lines of nonabsorbable
sutures and by avoiding the use of artificial meshes. 
The flap was then brought to the recipient site,
where it was revascularised by microsurgical arterial and
venous anastomosis to the thoracodorsal vessels. There-
after, the flap was shaped and adaptive reduction
mammaplasty was performed according to patients’
needs. 
Postoperatively the flaps were monitored by clinical
observation, temperature measurement and Doppler
flowmetry, and 10% dextran 40 (B. Braun Medical AG,
Emmenbrücke, Switzerland) was given at a rate of 50 ml
per hour until postoperative day four to support microcir-
culatory blood flow in the flap. Ambulation and respira-
tory physiotherapy were initiated as soon as the patient
was extubated. A tight bra and abdominal garment were
prescribed in all patients for four and six weeks respec-
tively.
The desired shape of the breast was commonly ac-
complished with a second procedure 6 to 9 months after
flap surgery. In the immediate reconstruction cases the
NAC was reconstituted by reimplanting the preserved
original NAC a few days postoperatively, provided that no
tumour infiltration was found in the histological sections
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of the retroareolar tissue. In the other patients and in the
secondary reconstructions the nipple was recreated using
a local flap or by transplanting a part of the contralateral
nipple or a piece of the labia minora, and the areola was
tattooed. 
The acquisition of data was in accordance with the
guidelines of the Ethics Committe of the Canton of
Berne and the informed consent of the patients. All pa-
tients were prospectively assessed for demographic data
as well as preoperative surgical and medical interven-
tions, including radiotherapy and chemotherapy. Postop-
eratively the patients were assessed for systemic compli-
cations, wound healing complications (total or partial flap
failure, infections, haematoma, seroma) and patency of
the abdominal wall at the donor site during the hospital
stay and the regular follow-ups in the outpatient clinic.
Partial flap failure included skin and fat necrosis. The
severity of the complication was validated according to
the need and numbers of revisional surgery. 
Final outcome was assessed at least six months after
the last reconstructive step. The aesthetic result was eval-
uated by the patients themselves and by visual examina-
tion by two independent staff members whose scores
were averaged. The aesthetic result was scored according
to shape, symmetry, scars, NAC and overall impression,
which were all checked for a possible relationship with
primary/delayed reconstruction or contralateral breast
reconstruction, smoking, overweight, wound healing
complications and numbers of corrective procedures 
Comparative statistical analysis was not performed
because randomisation was not given and the number of
covariates was too large for the sample size.
Results
Patients’ data: Thirty-two patients were in-
cluded in this study. The patients’ data are pre-
sented in table 1. The patients had a median age 
of 53 years and most were slightly overweight
(median BMI of 26). Twenty-two patients (69%)
presented with one or more systemic risk factors
(hypertension, diabetes mellitus, obesity, smok-
ing), and 19 patients (59%) with a local risk factor
(previous radiotherapy or abdominal surgery),
whereas only 6 patients (19%) had no risk factor.
Tumour size and stage were similar in both the
immediate and delayed reconstruction group. 
Surgery and hospitalisation: The reconstruction
was unilateral in 29 patients and bilateral in 3 pa-
tients (table 2). One patient with large breasts re-
ceived bilateral mastectomy and immediate re-
construction with a TRAM flap on one side and a
musculocutaneous latissimus dorsi flap and a sili-
cone prosthesis on the other. Fourteen patients
received immediate reconstruction but recon-
struction was delayed in the other 18. Ten patients
underwent simultaneous reduction mammaplasty
to achieve symmetrical breast size and ptosis, and
in another 8 patients this was accomplished dur-
ing a secondary adaptive procedure. The original
NAC was reimplanted in 4 immediate reconstruc-
tion patients, the nipple alone in another 7 cases.
Tattooing of the areola was performed in 23 pa-
tients, whereas 3 patients refused NAC recon-
struction and the original NAC was preserved in
the 2 subcutaneous mastectomy patients. One pa-
tient required revision of the arterial anastomosis
intraoperatively while all other flaps healed with-
out any thrombotic event at the site of the micro-
surgical anastomosis. The median operative time
was 7 h and the median hospital stay 11 days. The
duration of the hospital stay was not influenced by
the length of the surgical procedure. There were
no systemic complications such as thrombo -
embolism, pneumonia, or acute cardiovascular
events. An average of 1.06 procedures were per-
formed per patient to correct the shape of the re-
constructed breast with or without adaptive sur-
gery on the contralateral healthy side at a later
stage (33 operations).
Wound healing complications and donor site mor-
bidity: Ten patients had wound healing complica-
tions in the reconstructed breast, out of whom 
Age 35–68 (53) 
BMI (kg/m2) 20–39 (26)
Systemic risk factors 27
Arterial hypertension 1
Diabetes mellitus 1
Obesity (BMI >25) 16
Smoking 9
Local risk factors 19
Preoperative radiotherapy 2
Previous abdominal surgery 17
Indication for mastectomy
Proliferative mastopathy 3
In situ carcinoma 2
Invasive carcinoma 27
T1 9
T2 13
T3 2
T4 1
Unknown 2
Table 1 
Patients’ data 
(n = 32 patients),
range (median).
n Operative time Hospitalisation 
(min) (days)
Immediate unilateral reconstruction
With contralateral mammaplasty 2 410–540 (470) 10–11 (11)
Without contralateral mammaplasty 11 300–610 (400) 7–14 (11)
Delayed unilateral reconstruction
With contralateral mammaplasty 8 320–480 (430) 5–20 (11)
Without contralateral mammaplasty 8 260–540 (390) 7–13 (10)
Bilateral reconstruction 3 500–660 (520) 10–14 (11)
Table 2 
Surgery and hospitalisation (n = 32 patients), range (median). The values for operative
time are rounded to 2 significant digits.
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8 required surgical revision (table 3). Microcircu-
latory impairment led to tissue necrosis in the
wound margins of the original breast skin in 2 pa-
tients (14% of immediate reconstructions) with
subsequent lack of ptosis, and to partial flap fail-
ure in 5 cases (15%), out of which 4 (12% of flaps)
required surgical debridement and 1 healed spon-
taneously. One minor fat necrosis was biopsied 
8 months postoperatively. Wound healing compli -
cations occurred in 4 of the 9 smokers (44%) and
in 8 of the 16 overweight patients (50%), whereas
none of the 10 patients with a BMI below 24 suf-
fered partial flap necrosis. A similar rate of wound
healing complications was observed in immediate
and delayed reconstructions. Three surgical revi-
sions were necessary at the abdominal donor site
due to persistent seroma or bulging. Abdominal
bulging was seen in the two patients undergoing
bilateral reconstructions. It was preexistent in one
patient and related to flap harvesting in the other.
No abdominal hernia occurred.
Aesthetic assessment: One patient died as a re-
sult of the disease during the observation period,
and 5 failed to show up for the final assessment
due to a severe wound healing complication (1) or
for logistic reasons (4). The final outcome analysis
of the remaining 26 patients was performed 10 to
51 (median 27.5) months after TRAM flap sur-
gery. From the surgeon’s point of view, 18 (69%)
of the reconstructed breasts were judged to be
good, 7 (27%) fair and 1 (4%) poor, although
symmetry was considered to be achieved in only
53% of the unilateral breast reconstructions 
(fig. 1). The patients were even slightly more
pleased with the aesthetic outcome: 20 (77%)
rated the outcome as good, 5 (20%) as fair and 
1 (4%) as poor. The one poor result was attribut-
able to a major loss of original breast skin result-
ing in extensive scar formation and distortion of
the breast. However, there was no meaningful
correlation between the surgeons’ or patients’
evaluation of any type of procedure or predictive
risk factors except that primary reconstructions
tended to produce better scars. All but the dissat-
isfied patient would recommend the procedure to
a friend and spoke of improved self-esteem due to
the fact that their breast had been reconstructed
in the present manner. 
Total Spontaneous Surgical
healing revision
Recipient site
Skin necrosis 2 1 1
Infection 1 0 1
Seroma 1 0 1
Flap
Total flap loss 0
Partial tissue loss 5 1 4
Fat necrosis 1 0 1
Donor site
Hernia 0
Bulging 2 0 1
Seroma 1 0 1
Table 3 
Complications in
 reconstructed breast
(recipient site, flap)
and at abdominal
donor site (n = 32
 patients). The wound
healing complica-
tions healed sponta-
neously (n = 2) or
 required surgical
 revision (n = 8).
Discussion
Breast reconstruction with autologous tissue
is a constant battle between vascularisation of the
transplanted flap, donor site morbidity and aes-
thetic aspects, all of this taking place within the
framework of oncological requirements which
take absolute priority. Oncological safety was not
the subject of this study and has been widely con-
firmed for all procedures included in the present
concept [6, 7]. 
Impaired vascularisation is the main source of
wound healing complications at the site of the re-
constructed breast since it may eventually lead to
ischaemic necrosis. Besides prolonging the treat-
ment and necessitating repeated surgical correc-
tions, ischaemia-related necrosis may seriously
jeopardise the aesthetic outcome once a certain
amount of tissue is affected, as demonstrated by
the one poor result in this study. The preserved
original breast skin is particularly susceptible to
ischaemic tissue loss if additional incisions are
performed to reduce excessive skin [5], and they
have therefore been omitted in our recent cases.
Another area at risk is the flap tissue on the con-
tralateral side of the vascular pedicle, as shown in
the five patients undergoing partial flap loss in our
series. Such complications can be avoided if the
contralateral flap portions are discarded. How-
ever, this may limit the possibility of achieving
symmetrical breast size and is therefore contrary
to our therapeutic concept. In addition, our re-
sults suggest that ischaemia-related wound heal-
ing complications are increased by smoking and
overweight, as confirmed in the largest published
series of free TRAM flap reconstructions [16–20]. 
The worst vascular complication consists in
total loss of the transplanted flap tissue due to
thrombosis of the microvascular anastomoses, a
scenario that did not occur in our series and has
become very rare in the hands of experienced mi-
crosurgeons [16, 19]. Total flap loss may be cir-
cumvented if the flap is transferred in a pedicled
manner, where the blood supply is provided by
the superior epigastric vessels passing through the
superior parts of the rectus muscle serving as the
flap pedicle, as originally described [12]. However,
because this is not the axial anatomical blood sup-
ply to the transplanted infraumbilical flap tissue, it
increases the risk of critical ischaemia in the con-
tralateral flap tissue and the subsequent above-
mentioned complications [21]. 
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Another major factor in favour of free flap
transfer is that the donor site defect can be re-
stricted to the lower abdomen. Long-term donor
site morbidity is characterised by herniation or
bulging of the abdominal wall. No hernias oc-
curred in our series, but one patient developed
surgery-related abdominal bulging after bilateral
flap harvest. Abdominal wall instability has been
thought to correlate with the size of the abdomi-
nal wall defect [22–24], which provided the impe-
tus for the development of the deep inferior epi-
gastric perforator (DIEP) flap [25]. With this
technique the entire rectus abdominis muscle is
left in place, a position which can be achieved by
dissecting 1 to 3 nourishing perforators out of the
muscle. However, with our refined fascia- and
muscle-sparing dissection technique [26] we were
able to reduce abdominal wall instability to the
level of DIEP flaps [27, 28] without the use of al-
loplastic material. 
Overall  satisfaction with the final result was
high among the surgeons, and even slightly
higher among the patients, as frequently reported
in aesthetic outcome studies [4, 9, 29]. While ac-
cepting the result represents an important step in
working up the psychological impact of the dis-
ease for the patient, the surgeon tends to have a
critical attitude towards his work in terms of striv-
ing for betterment. Although similar patient satis-
faction can be achieved with implants with or
without additional soft tissue reconstructions [3,
9, 15], approximately half of those patients may
require additional surgery in the long term due to
prosthesis dislocation, capsular contraction or im-
plant rupture [9], whereas the natural appearance
after TRAM flap reconstruction remains unaf-
fected once it is in place. Most interestingly, in
some comparative outcome assessment studies [4,
29, 30] breast reconstruction with autologous tis-
sue yielded similar or even greater patient satis-
faction than breast conserving surgery in terms of
health-related quality of life and cosmetic out-
come, whereas the patients’ body image scores
were significantly lower and regrets at their deci-
sion keener in patients undergoing mastectomy
without reconstruction [3, 4]. Considering that
cosmesis and satisfaction after breast conserving
surgery correlates with the percentage of breast
volume excised [31], this may shift the decision
towards mastectomy and immediate reconstruc-
tion with autologous tissue in cases of high tu-
mour-to-breast volume ratio.
The aesthetic outcome is determined by the
shape, size and symmetry of the reconstruction as
well as scars and the appearance of the NAC. All
these factors can be markedly improved with the
skin sparing mastectomy technique (fig. 2): the
original skin texture and colour are maintained,
the envelope provides a natural breast shape, and
the scars can be hidden around the natural aes-
thetic borderline between breast skin and NAC.
Although skin sparing mastectomy is normally
 restricted to patients receiving immediate breast
Figure 1
Surgeon’s and pa-
tient’s evaluation 
of the aesthetic out-
come after breast
 reconstruction with
TRAM flaps (n = 26,
median follow-up
27.5 months).
Overall satisfaction
Shape
Symmetry
Nipple-areola complex
Scars
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reconstruction, it can also be applied if the recon-
struction has to be delayed, eg due to adjuvant
 radiotherapy, which may jeopardise the aesthetic
outcome after immediate reconstruction. In this
scenario, we recommend inserting a breast im-
plant as a filler to maintain the shape of the breast
skin envelope until the definitive  reconstruction
can be performed.
We conclude that a high satisfaction rate and
a good and permanent aesthetic outcome were
obtained with breast reconstruction with autolo-
gous abdominal tissue, although repetitive, partly
invasive surgical procedures were required and a
relatively high rate of ischaemia-related wound
healing complications occurred. This justifies our
strategy of including patients presenting risks
such as smoking and overweight. The risk of
wound healing complications is minimised by free
instead of pedicled tissue transfer, and by includ-
ing a maximum number of feeding perforators
into the flap. We developed a fascia-sparing dis-
section method to ensure the latter without jeop-
ardising abdominal wall stability. Careful atten-
tion was paid to sparing the original breast skin
envelope in order to maintain natural shape, skin
texture and colour, and to avoiding scars except
around the reconstructed NAC. These data may
be of help in the decision-making process of
 patients eligible for breast reconstruction after
mastectomy.
Correspondence:
Prof. D. Erni
Department of Plastic and Hand Surgery
Inselspital, University of Berne
CH-3010 Berne
Switzerland
E-Mail: dominique.erni@insel.ch
Figure 2
Delayed recon-
struction (above).
Sixty-seven year old
patient 12 months
after delayed breast
reconstruction with
free TRAM flap and
contralateral breast
reduction, and 
8 months after NAC
 reconstruction with
nipple-share from the
healthy side and tat-
tooing of the areola.
Immediate recon-
struction (below).
Sixty-four year old
patient 13 months
after skin sparing
mastectomy and im-
mediate breast recon-
struction with TRAM
flap, nipple recon-
struction with reim-
plantation of the orig-
inal nipple and areola
tattooing. Skin spar-
ing mastectomy
maintains the natural
shape, texture and
colour of the breast
and provides incon-
spicuous scars
placed in the natural
aesthetic borderline
defining the circum-
ference of the areola.
The scar at the ab-
dominal donor site is
hidden by the under-
wear in both patients.
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